Similar articles

• [Depression in alcohol addicted patients].

  Ponizovskiy PA, Gofman AG. Ponizovskiy PA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(7):146-150. doi: 10.17116/jnevro201511571146-150. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26356528 Review. Russian.
• Occurrence and management of depression in the context of naltrexone treatment of alcoholism.

  Farren CK, O'Malley SS. Farren CK, et al. Am J Psychiatry. 1999 Aug;156(8):1258-62. doi: 10.1176/ajp.156.8.1258. Am J Psychiatry. 1999. PMID: 10450269 No abstract available.
• Current pharmacotherapies of alcoholism: a U.S. perspective.

  Anton RF, Swift RM. Anton RF, et al. Am J Addict. 2003;12(s1):s53-s68. doi: 10.1111/j.1521-0391.2003.tb00496.x. Am J Addict. 2003. PMID: 14972780 Review.
• Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

  Kranzler HR, Van Kirk J. Kranzler HR, et al. Alcohol Clin Exp Res. 2001 Sep;25(9):1335-41. Alcohol Clin Exp Res. 2001. PMID: 11584154 Clinical Trial.
• [Alcohol--mechanism of action, interactions and treatment of alcohol abuse].

  Korpi E, Seppälä T. Korpi E, et al. Duodecim. 1998;114(10):1029-36. Duodecim. 1998. PMID: 11524777 Review. Finnish. No abstract available.